Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults
- PMID: 40938541
- DOI: 10.1007/s11920-025-01638-0
Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults
Abstract
Purpose: Despite more recent declines in opioid overdose deaths, opioid use among adolescents and young adults (AYA) continues to be a significant public health crisis in the U.S., contributing to various adverse health outcomes. We summarized peer-reviewed literature on the prevalence, risk factors, treatment options, and barriers to evidence-based care for AYA with opioid misuse and opioid use disorder (OUD).
Recent findings: Despite the significant need, treatment access for OUD among AYA is low, with limited utilization of evidence-based practices including medications for OUD (MOUD). Primary barriers to effective treatment include inadequate healthcare provider training, a shortage of specialized facilities, prevalent stigma towards treatment, and prohibitive costs. Furthermore, greater naloxone distribution is necessary to reduce overdose deaths in this population. Comprehensive efforts to enhance MOUD accessibility, integrate behavioral interventions, reduce stigma, and support ongoing research into effective AYA-specific strategies are needed to address this national crisis.
Keywords: Adolescents; Medication for opioid use disorder; Opioid misuse; Opioid use disorder; Young adults; Youth.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Study Protocol for Implementation of Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorder for Incarcerated Individuals (PLI-MOUD Study).Subst Use Addctn J. 2025 Oct;46(4):1034-1039. doi: 10.1177/29767342251333241. Epub 2025 Apr 29. Subst Use Addctn J. 2025. PMID: 40302312
-
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural Settings.JAACAP Open. 2024 Feb 28;2(4):231-238. doi: 10.1016/j.jaacop.2024.02.001. eCollection 2024 Dec. JAACAP Open. 2024. PMID: 39697397 Free PMC article.
-
Opioid agonist therapy for opioid use disorder in primary versus specialty care.Cochrane Database Syst Rev. 2025 Sep 8;9(9):CD013672. doi: 10.1002/14651858.CD013672.pub2. Cochrane Database Syst Rev. 2025. PMID: 40919724
-
Medication for opioid use disorder in the Arab World: A systematic review.Int J Drug Policy. 2022 Apr;102:103617. doi: 10.1016/j.drugpo.2022.103617. Epub 2022 Feb 16. Int J Drug Policy. 2022. PMID: 35182841 Free PMC article.
References
-
- Committee USJE, The Economic Toll of the Opioid Crisis Reached Nearly. $1.5 Trillion in 2020 - The Economic Toll of the Opioid Crisis Reached Nearly $1.5 Trillion in 2020 - United States Joint Economic Committee [Internet]. [cited 2025 Aug 9]. Available from: https://www.jec.senate.gov/public/index.cfm/democrats/2022/9/the-economi...
Publication types
LinkOut - more resources
Full Text Sources